Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation

Fig. 2

PRDM1 and PRDM2 relative gene expression by qRT-PCR analysis in activated T cell treated with Ly, PP1 Src kinase inhibitor and Wortamannin PI3K inhibitor for 2 h and 6 h. PRDM1 and PRDM2 transcript levels were compared to their expression in naïve T cells (with expression value equal to 1). RPS18 was used as control gene. Three independent experiments in triplicates were performed and data expressed as mean ± SD. ns (not significant), *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page